Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
about
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology.Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literatureA proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patientsManagement of poor responders in IVF: is there anything new?A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatmentEfficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy.Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells.Serum luteinizing hormone level on the third day after ovarian stimulation in GnRH agonist short protocol is predictive of outcome in poor responders but not in normal responders.Individualized controlled ovarian stimulation in expected poor-responders: an update.Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine ErDefining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why
P2860
Q26800627-2A0F0AE6-E355-432D-99CA-96076A768E87Q30399240-D487C9A2-72CC-4604-BFE3-C3EEDE452A47Q33743109-B5227CBB-F585-4B7C-9ABB-201F2E04CB74Q33828136-408AC29A-51F6-4432-B79E-75EB8BCA0346Q34022512-56519A3A-2DA6-4F8E-AA6A-BD2B762B4B20Q34875744-EEBD78DC-75B5-4A40-B6C2-CEB7F1EAF60DQ35713241-189F2B5B-DD43-4780-A009-29127F40068DQ35844053-BA197187-DB53-45EA-BB46-6565D01EFF5AQ38381555-2A0EADD4-8D2D-49C7-ABAA-E06817705654Q38602011-E7775D9A-4D42-48FE-964E-969AD02975E5Q41708984-BFEE1475-90A2-4CA0-95C9-36E77FF7B106Q42373472-6F076A8C-B6DC-4671-A9F4-92B8C2107008Q48583994-6575D709-A433-44B3-B178-64778FB86E4AQ48599302-101AEB0E-C480-4736-B994-FB43F3ADBAB1Q50437677-F6778719-CBFA-482F-B863-993256D62B94Q51037960-AF22A421-290B-4943-A4CD-1CE7E46003BCQ52663984-C211F98F-1F42-44F5-8CC1-0042C31859FDQ55344932-2E08EE66-91BF-43BE-A664-F7679FEF2541Q58769667-256B6F5D-014F-4E05-A95A-30720A276E70
P2860
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recombinant human follicle-sti ...... atic review and meta-analysis.
@ast
Recombinant human follicle-sti ...... atic review and meta-analysis.
@en
Recombinant human follicle-stimulating hormone
@nl
type
label
Recombinant human follicle-sti ...... atic review and meta-analysis.
@ast
Recombinant human follicle-sti ...... atic review and meta-analysis.
@en
Recombinant human follicle-stimulating hormone
@nl
prefLabel
Recombinant human follicle-sti ...... atic review and meta-analysis.
@ast
Recombinant human follicle-sti ...... atic review and meta-analysis.
@en
Recombinant human follicle-stimulating hormone
@nl
P2093
P2860
P921
P356
P1476
Recombinant human follicle-sti ...... matic review and meta-analysis
@en
P2093
Basil Tarlatzis
Efstratios M Kolibianakis
Helen Saunders
Joan Schertz
Pablo Arriagada
Philippe Lehert
Samuel Copt
P2860
P2888
P356
10.1186/1477-7827-12-17
P577
2014-02-20T00:00:00Z
P5875
P6179
1049046409